Dr. Nazzal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 E 41st St
New York, NY 10017Phone+1 646-825-6300Fax+1 646-825-6399
Education & Training
NYU Grossman School of MedicineFellowship, Nephrology, 2011 - 2013
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2008 - 2011
American University of Beirut Faculty of MedicineClass of 2006
Certifications & Licensure
NY State Medical License 2014 - 2025
Clinical Trials
- Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients Start of enrollment: 2016 Jun 01
- Bucillamine Phase 2 Trial in Patients With Cystinuria Start of enrollment: 2017 May 01
Publications & Presentations
PubMed
- 76 citationsEnteric hyperoxaluria: an important cause of end-stage kidney diseaseLama Nazzal, Sonika Puri, David S. Goldfarb
Nephrology, Dialysis, Transplantation. 2016-03-01 - 34 citationsOxalate homeostasis.Theresa Ermer, Lama Nazzal, Maria Clarissa Tio, Sushrut Waikar, Peter S Aronson
Nature Reviews. Nephrology. 2023-02-01 - 25 citationsForty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.Steven L. Daniel, Luke Moradi, Henry Paiste, Kyle Wood, Dean G. Assimos
Applied and Environmental Microbiology. 2021-08-26
Press Mentions
Study Suggests Oral Antibiotics May Increase Kidney Stone RiskMay 10th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
